APA (7th ed.) Citation

R, S., P, C., O, D., LP, Z., M, R., E, Z., . . . A, M. (2025). Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors. HemaSphere, 9(11), e70256. https://doi.org/10.1002/hem3.70256

Chicago Style (17th ed.) Citation

R, Stammler, et al. "Inflammatory Disorders in IDH-mutated Myeloid Neoplasms: Characteristics and Response to IDH Inhibitors." HemaSphere 9, no. 11 (2025): e70256. https://doi.org/10.1002/hem3.70256.

MLA (9th ed.) Citation

R, Stammler, et al. "Inflammatory Disorders in IDH-mutated Myeloid Neoplasms: Characteristics and Response to IDH Inhibitors." HemaSphere, vol. 9, no. 11, 2025, p. e70256, https://doi.org/10.1002/hem3.70256.